A recent study using the SEER database, with historical data prior to and after 2015, indicated a significant improvement in BC‐specific survival on a population level, potentially due to the introduction of CDK4/6is post 2015 specifically in the HR+/HER− population [19]. The gene discussed is CDK4; the disease is breast cancer.